Cybin's new financing is priced at CAD$3.40. The Company intends to issue 8.8 million new units for total proceeds of CAD$30 million.
Cybin's new financing is priced at CAD$3.40. The Company intends to issue 8.8 million new units for total proceeds of CAD$30 million.
The Mental Health Crisis has been ignored for decades. Covid-19 has made this mental health catastrophe much worse -- and people are now starting to notice.
Cybin Inc is seeking to raise capital with an overnight offering of common shares. Pricing and size of the offering to be determined.
Field Trip Health to commence trading on the NASDAQ on July 27th under the symbol "FTRP".
MINDCURE's proprietary ibogaine manufacturing has reached the second stage of development: assessing the quality of its synthetic ibogaine.
We explain why addiction therapy likely offers the greatest long-term commercialization potential within the psychedelic drug industry.
Red Light Holland reports an updated position in cash and cash equivalents of roughly CAD$30 million following its merger with Creso Pharma.
Levitee Labs announces definitive agreements to acquire 3 specialized pharmacies, a "leading telehealth provider", and 5 addiction clinics.
Field Trip Health has received conditional approval to list on the NASDAQ, symbol "FTRP".
Psyched Wellness announces the largest extraction and shipment of its flagship nootropic (AME-1) to Asia.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now